 |
 |
In a message dated 6/3/2002 8:05:31 AM, [log in to unmask] writes: << A scientific collaboration based at the University of North Carolina at Chapel Hill has broken new ground for future drug design and development for brain disorders such as Parkinson's disease and schizophrenia. http://www.datamonitor.com/~8e89872bf42646f387179b0f9adea30e~/all/news/product .asp?pid=094EDE01-FD11-428E- A354-56D544B1D94F >> Hi all, Couldn't access this article for some reason but did find another encouraging piece in Datamonitor...here it is (keep scrolling). Regards, Kathleen Human cloning research remains possible as issue over ban splits Senate 31 May 2002Proposed legislation standing before the US Senate regarding the restriction of human cloning has been delayed due to a lack of support. The two camps remain divided with one bill proposing to allow only the cloning of embryos and the other committing to outlaw cloning altogether.Whilst the Senate has been unable to agree on the extent of a cloning ban, the division may actually result in greater research into the subject. The failure of any ruling to be passed has left few limits preventing cloning studies taking place. It is thought that some pharmaceuticals and certain biotechnology organizations could begin the funding of cloning research as a result. The Biotechnology Industry Organization has indicated that there are already a number of groups involved in this research, such as Geron and Advanced Cell Technology. These companies recognize that with the Senate unable to reach a collective decision they have more time to illustrate the benefit of cloning, through the development of treatments for diseases for example. The US could be left in a much more liberal position on this controversial issue, unlike the stances adopted by Britain and France. According to the Financial Times, individual US states may well be forced to pass their own legislation governing cloning. ---------------------------------------------------------------------- To sign-off Parkinsn send a message to: mailto:[log in to unmask] In the body of the message put: signoff parkinsn